Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0000899243-22-013305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-04 | 2022-03-31 | VRTX | MCGLYNN MARGARET G | Dir | M - OptEx | $127.54 | +5,000 | 6,099 | +455% | +$637.7K |
| DM | 2022-04-04 | 2022-03-31 | VRTX | MCGLYNN MARGARET G | Dir | S - Sale+OE | $262.27 | -5,000 | 5,080 | -50% | -$1.31M |
| D | 2022-04-04 | 2022-03-31 | VRTX | MCGLYNN MARGARET G | Dir | M - OptEx | $127.54 | -5,000 | 10.0K | -33% | -$637.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | M | A | 5,000 | $127.54 | 6,099 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-31 | S | D | 1,011 | $262.97 | 1,099 | D | — | — | (F3) Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $262.97 (range $262.80 to $263.34). |
| 3 | Common | Common Stock | 2022-03-31 | S | D | 2,970 | $262.37 | 2,110 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $262.37 (range $261.79 to $262.78). (F3) Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-03-31 | S | D | 1,019 | $261.28 | 5,080 | D | — | — | (F3) Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F2) Open market sales reported on this line occurred at a weighted average price of $261.28 (range $260.78 to $261.73). |
| 5 | Derivative | Common Stock (right to buy) | 2022-03-31 | M | D | 5,000 | $127.54 | 10,000 | D | $127.54 · — to 2025-05-31 | 5,000 Common Stock | (F6) Fully vested |